HPV-test, Cervical Cancer and Follow-up

• Conditions: Human Papilloma Virus; Uterine Cervical Neoplasms; Recurrence

• Registration Number: NCT02096016
• Lead Sponsor: University of Aarhus

Brief Summary

The investigators have planned this project to evaluate the follow-up program after surgery due to cervical cancer and to explore the possibilities for different tests of Human Papilloma Virus (HPV) in contributing to the customization of the follow-up program.

Purpose:

The investigators effort is to provide the background for an evidence-based update of the follow-up program after surgery due to cervical cancer with the purpose of early diagnosis of recurrence affecting quality of life for as few women as possible.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-01
• Study First Submitted: 2014-03-21
• Study First Submitted QC: 2014-03-24
• Study First Posted: 2014-03-26
• Status Verified: 2017-04
• Last Update Submitted: 2017-04-11
• Last Update Posted: 2017-04-12
• Primary Completion: 2019-10
• Study Completion: 2019-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 50

Inclusion Criteria

• Surgery. FIGO stage IA-IB. > 18 years

Exclusion Criteria

• Ajuvant oncologic treatment

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prevalence of HPV Genotypes in Vagina (Type 16, 18 and Other)	2 years

Secondary Outcome Measures

Name	Time	Method
HPV Clearance From Vagina in Between the Two Planned Follow-up Visits.	2 years

Trial Locations

Locations (1)

Aarhus University Hospital; 🇩🇰 Aarhus, Denmark